Options

iSIGN Media Announces the Close of its Previously Announced Private Placement of up to $1.2 million

Retrieved on: 
Friday, September 3, 2021

With this Final Tranche, the Company has received funds totaling $832,510 and has issued a total of 16,650,200 Units (Units) at a price of $0.05 per Unit.

Key Points: 
  • With this Final Tranche, the Company has received funds totaling $832,510 and has issued a total of 16,650,200 Units (Units) at a price of $0.05 per Unit.
  • The proceeds of the Placement will be for new software development and enhancements to existing technologies and operational purposes.
  • The forward-looking statements are not historical facts but reflect iSIGN Medias current expectations regarding future results or events.
  • iSIGN Media assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Xigem Technologies Announces Shares for Debt Transaction and Warrant Exercise

Retrieved on: 
Friday, September 3, 2021

The Shares will be subject to a four-month hold period in accordance with applicable securities laws.

Key Points: 
  • The Shares will be subject to a four-month hold period in accordance with applicable securities laws.
  • All share issuances are subject to applicable regulatory approval, including the approval of the Canadian Securities Exchange.
  • The Company also announced the recent exercise of certain warrants at an exercise price of $0.07 per common share of Xigem (the "Warrants").
  • To date, 2,275,000 Warrants have been exercised for gross proceeds of $159,250.

Allogene Therapeutics Reports Second Quarter 2021 Financial Results

Retrieved on: 
Wednesday, August 4, 2021

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today provided a corporate update and reported second quarter 2021 financial results for the quarter ended June 30, 2021.

Key Points: 
  • Initial Clinical Readout Expected in 2022
    Appointed Liz Barrett and Vicki Sato, Ph.D., Executives with Significant Strategic and Commercial Expertise, to the Board of Directors
    State-of-the-Art cGMP Manufacturing Facility in Newark, California to Support Industrys First Allogeneic Pivotal Trial and Future Commercial Launch
    Ended Second Quarter with$913 Millionin Cash, Cash Equivalents and Investments
    SOUTH SAN FRANCISCO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc.(Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) therapies for cancer, today provided a corporate update and reported second quarter 2021 financial results for the quarter ended June 30, 2021.
  • Research and development expenses were$52.3 millionfor the second quarter of 2021, which includes$10.5 millionof non-cash stock-based compensation expense.
  • General and administrative expenses were$18.8 millionfor the second quarter of 2021, which includes$10.6 millionof non-cash stock-based compensation expense.
  • Net loss for the second quarter of 2021 was$70.9 million, or$0.53per share, including non-cash stock-based compensation expense of$21.1 million.

Thinking about trading options or stock in Activision Blizzard, BioNTech, Caesars Entertainment, Pfizer, or Advanced Micro Devices?

Retrieved on: 
Wednesday, August 4, 2021

NEW YORK, Aug. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATVI, BNTX, CZR, PFE, and AMD.

Key Points: 
  • NEW YORK, Aug. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATVI, BNTX, CZR, PFE, and AMD.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

EarthRenew Announces First 6 Months Revenue and Option Grant

Retrieved on: 
Tuesday, August 3, 2021

EarthRenew is also reporting power generation revenue for the first 6 months of 2021 totalling $0.65 million.

Key Points: 
  • EarthRenew is also reporting power generation revenue for the first 6 months of 2021 totalling $0.65 million.
  • EarthRenew has granted a total of 3,890,000 stock options to certain officers, directors, employees, and consultants of the Company pursuant to the Companys stock option plan.
  • The stock options vest immediately and may be exercised at a price of $0.25per option for a period of five years from the date of grant.
  • EarthRenew benefits from multiple revenue streams including, primarily, the sale of regenerative fertilizers, but also enjoys secondary revenue from generating power and selling surplus electricity.

Chavant Capital Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on August 10, 2021

Retrieved on: 
Tuesday, August 3, 2021

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into ordinary shares and warrants.
  • About Chavant Capital Acquisition Corp.
    Chavant Capital Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the SEC) on July 19, 2021.

Cboe Global Markets to Present at UBS Financial Services Virtual Conference Tuesday, August 10

Retrieved on: 
Tuesday, August 3, 2021

CHICAGO, Aug. 3, 2021 /PRNewswire/ --Cboe Global Markets, Inc. (Cboe: CBOE), a leading provider of global market infrastructure and tradable products, announced today that Chris Isaacson, Executive Vice President and Chief Operating Officer, and Brian Schell, Executive Vice President, Chief Financial Officer and Treasurer, will present at the UBS Financial Services Virtual Conference, on Tuesday, August 10 at 1:00 p.m.

Key Points: 
  • CHICAGO, Aug. 3, 2021 /PRNewswire/ --Cboe Global Markets, Inc. (Cboe: CBOE), a leading provider of global market infrastructure and tradable products, announced today that Chris Isaacson, Executive Vice President and Chief Operating Officer, and Brian Schell, Executive Vice President, Chief Financial Officer and Treasurer, will present at the UBS Financial Services Virtual Conference, on Tuesday, August 10 at 1:00 p.m.
  • The webcast and replay of the virtual presentation can be accessed at www.cboe.com in the Investor Relations section, under Events and Presentations.
  • Cboe Global Markets (Cboe: CBOE), a leading provider of market infrastructure and tradable products, delivers cutting-edge trading, clearing and investment solutions to market participants around the world.
  • The company is committed to operating a trusted, inclusive global marketplace, providing leading products, technology and data solutions that enable participants to define a sustainable financial future.

Infrastructure and Energy Alternatives, Inc. Closes Public Offering of Common Stock and Pre-Funded Warrants

Retrieved on: 
Monday, August 2, 2021

INDIANAPOLIS, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Infrastructure and Energy Alternatives, Inc. (IEA) (NASDAQ: IEA or the Company) today announced the closing of its underwritten public offering of common stock and pre-funded warrants to purchase shares of common stock.

Key Points: 
  • INDIANAPOLIS, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Infrastructure and Energy Alternatives, Inc. (IEA) (NASDAQ: IEA or the Company) today announced the closing of its underwritten public offering of common stock and pre-funded warrants to purchase shares of common stock.
  • At closing, IEA issued 10,547,866 shares of its common stock and pre-funded warrants to purchase 7,747,589 additional shares of its common stock.
  • The shares of common stock and pre-funded warrants were sold at a price to the public of $11.00 per share of common stock and $10.9999 per pre-funded warrant.
  • The underwriting discounts and commissions for shares of common purchased by public investors was $0.66 per share of common stock.

Logistics Innovation Technologies Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about August 2, 2021

Retrieved on: 
Monday, August 2, 2021

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into shares of Class A common stock and warrants.
  • A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the SEC) on June 10, 2021.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

CleanTech Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing August 4, 2021

Retrieved on: 
Saturday, July 31, 2021

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • The common stock, rights and warrants that are separated will trade on Nasdaq under the symbols "CLAQ," "CLAQR" and "CLAQW," respectively.
  • Those units not separated will continue to trade on Nasdaq under the symbol CLAQU.
  • A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on July 14, 2021.